Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 36 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Vincent P.

United States

USD 36 /hr

Project Mnager for pharmaceutical industry | Neurodegenerative diseases | immunology

Profile Summary

PhD in molecular medicine with a focus on innate immune cells in Alzheimer’s and multiple sclerosis. Project manager for the industry, I not what are the hot spots in neurosciences and can bring you my expertise and my vision on different diseases and cellular pathways.

Subject Matter Expertise

• ★ Neuroscience
• ★ Rare Diseases
• ★ Project Management
• ☆ Clinical Trials
• ☆ Neurology
• ☆ Multiple Sclerosis

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Non-Medical Regulatory Writing, Technical Writing, Newswriting, General Proofreading & Editing, Translation

Research Market Research, User Research, Feasibility Study, Fact Checking, Scientific and Technical Research, Systematic Literature Review

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis

Product Development Product Validation

Work Experience

Associate Study Director

The Jackson Laboratory

January 2023 - Present

Laboratory Director

Centre de recherche du CHUQ

December 2020 - February 2022

Education

PhD

Université Laval

September 2017 - December 2020

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Vincent Pons, Pierre-Alexandre Piec, Paul Préfontaine, Serge Rivest (2022). Muramyl Dipeptide Administration Delays Alzheimer’s Disease Physiopathology via NOD2 Receptors . Cells.

Pierre-Alexandre Piec, Paul Préfontaine, Serge Rivest, Vincent Pons (2022). Muramyl Dipeptide Administration Delays Alzheimer’s Disease Physiopathology via NOD2 Receptors . Cells.

Sarah Lecordier and Vincent Pons and Serge Rivest and Ayman ElAli(2022). Multifocal Cerebral Microinfarcts Modulate Early Alzheimer’s Disease Pathology in a Sex-Dependent Manner . Frontiers in Immunology. 12. Frontiers Media {SA}

Vincent Pons and Serge Rivest(2022). Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease . Pharmacological Reviews. 74. (1). p. 1--17. American Society for Pharmacology {\&} Experimental Therapeutics ({ASPET})

Vincent Pons and Pascal L{\'{e}}vesque and Marie-Mich{\`{e}}le Plante and Serge Rivest(2021). Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer’s disease . Alzheimer's Research & Therapy. 13. (1). Springer Science and Business Media {LLC}

Vincent Pons and Pascal L{\'{e}}vesque and Marie-Mich{\`{e}}le Plante and Serge Rivest(2021). Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer’s disease . Alzheimer's Research & Therapy. 13. (1). Springer Science and Business Media {LLC}

Pierre-Alexandre Piec and Vincent Pons and Serge Rivest(2021). Triggering Innate Immune Receptors as New Therapies in Alzheimer’s Disease and Multiple Sclerosis . Cells. 10. (8). p. 2164. {MDPI} {AG}

Vincent Pons, Pierre-Alexandre Piec, Serge Rivest (2021). Triggering Innate Immune Receptors as New Therapies in Alzheimer’s Disease and Multiple Sclerosis . Cells.

Giulia Cisbani and Silvia Poggini and Nataly Laflamme and Vincent Pons and Marie-{\`{E}}ve Tremblay and Igor Branchi and Serge Rivest(2021). The Intellicage system provides a reproducible and standardized method to assess behavioral changes in cuprizone-induced demyelination mouse model . Behavioural Brain Research. 400. p. 113039. Elsevier {BV}

Vincent Pons and Serge Rivest(2020). Beneficial Roles of Microglia and Growth Factors in MS, a Brief Review . Frontiers in Cellular Neuroscience. 14. Frontiers Media {SA}

Shehata Anwar and Vincent Pons and Serge Rivest(2020). Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases . Cells. 9. (7). p. 1595. {MDPI} {AG}

Vincent Pons and Nataly Laflamme and Paul Pr{\'{e}}fontaine and Serge Rivest(2020). Role of Macrophage Colony-Stimulating Factor Receptor on the Proliferation and Survival of Microglia Following Systemic Nerve and Cuprizone-Induced Injuries . Frontiers in Immunology. 11. Frontiers Media {SA}

Vincent Pons and Serge Rivest(2018). New Therapeutic Avenues of mCSF for Brain Diseases and Injuries . Frontiers in Cellular Neuroscience. 12. Frontiers Media {SA}